Summary
The M.avium complex consists of a group of environmental mycobacteria that are important opportunistic human pathogens for a variety of immunosup- pressed cancer, transplant, and HIV-infected patients.Some members of this group are able to colonize the nasopharyngeal and intestinal mucosal membranes of normal individuals who may go on to develop a self-limiting lymphadenitis. The more virulent strains within this group may produce slow,indolent lung disease in some tuberculosis patients as well as in terminally ill renal, diabetic, and cancer patients. More aggressive systemic infections will develop in congenitally and iatrogenically immunosuppressed patients. As much as 60% of AIDS patients have been reported to be infected with nontuberculous mycobacteria, the most common of which are M.avium-complex s rovars 1, 4, 6, and 8. Half of these patients go on to develop a life-threatening, disseminated form of this disease that can markedly reduce their survival and quality of life. The high level of drug resistance exhibited by these organisms makes ffective chemotherapy difficult to achieve and maintain. The response to these drugs is bacteriostatic rather than bactericidal and the disease recurs whenever therapy is discontinued, usually as result of the increasing toxicity of the drug regimen. Development of a suitable immunotherapeutic intervention to help restore cellular immunity to the HIV-infected patient takes on an increasingly urgent priority as the worldwide HIV-MAC epidemic continues its relentless spread.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Collins, F. M., 1982, Immunology of tuberculosis, Am. Rev. Respir. Dis. 125:42–49.
Wolinsky, E., 1984, Nontuberculous mycobacteria and associated diseases, in: The Mycobacteria: A Sourcebook, Vol. 2 (G. P. Kubica and L. G. Wayne, eds.), Marcel Dekker, New York, pp. 1141–1208.
Wayne, L. G., 1984, Mycobacterial speciation, in The Mycobacteria: A Sourcebook, Vol. 1 (G. P. Kubica and L. G. Wayne, eds.), Marcel Dekker, New York, pp. 25–65.
Wayne, L. G., 1985, The ‘atypical’ mycobacteria: Recognition and disease association, Crit. Rev. Microbiol. 12:185–222.
McClatchy, J. K., 1981, The seroagglutination test in the study of nontuberculous mycobacteria, Rev. Infect. Dis. 3:867–870.
Wayne, L. G., Good, R. C., Tsang, A., et al., 1993, Serovar determination and molecular taxonomic correlation in Mycobacterium avium, M. intracellulare and M. scrofulaceum: A cooperative study of the International Working Group on Mycobacterial Taxonomy, Int. J. Syst. Bacteriol. 43:482–489.
Yajko, D. M., Chin, D. P., Gonzalez, P. C., et al., 1995, M. avium-complex in water, food and soil samples collected from the environment of HIV-infected individuals, J. AIDS 9:176–182.
Young, L. S., Inderlied, C. B., Berlin, O. G., and Gottlieb, M. S., 1986, Mycobacterial infections in AIDS patients with an emphasis on the Mycobacterium avium complex, Rev. Infect. Dis. 8:1024–1033.
Piot, P., Loga, M., Ryder, R., et al., 1990, The global epidemiology of HIV infection: Continuity, heterogenicity and change, J. AIDS 3:403–412.
Dolin, P. J., Raviglione, M. C., and Kochi, A., 1992, Global tuberculosis incidence and mortality during 1990–2000, Bull. WHO 72:213–220.
Centers for Disease Control, 1995, First 500,000 AIDS cases—United States, 1995, Morb. Mort. Wk. Rep. 44:849–853.
Bermudez, L. E., 1994, Immunobiology of Mycobacterium avium infection, Eur. J. Clin. Microbiol. Infect. Dis. 13:1000–1006.
O’Brien, R. J., Geiter, L. J., and Snider, D. E., 1987, The epidemiology of nontuberculous mycobacterial diseases in the United States, Am. Rev. Respir. Dis. 135:1007–1014.
Hoffner, S. E., Petrini, B., Brennan, P. J., et al., 1989, AIDS and M. avium serotypes in Sweden, Lancet ii:336–337.
Kiehn, T. E., Edwards, F. F., Brannon, P., Tsang, A., Maio, M., Gold, J., Whinberg, E., Wang, B. McClatchy, J. K., and Armstrong, D. 1985, Infections caused by M. avium-complex in immunocompromised patients: Diagnosis by blood culture and fecal examination, antimicrobial susceptibility test and morphological and serological characteristics, J. Clin. Microbiol. 21:168–173.
von Reyn, C. F., Maslow, J. N., Barber, T. W., et al., 1994, Persistent colonization of potable water as a source of M. avium infection in AIDS, Lancet 343:1137–1141.
duMoulin, G. C., and Stottmeier, K. D., 1986, Waterborne Mycobacteria: An increasing threat to health, ASM News 52:525–529.
Gruft, H., Falkinham, J. O., and Parker, B. C., 1981, Recent experience in the epidemiology of disease caused by atypical mycobacteria, Rev. Infect. Dis. 3:990–996.
Romanus, V., 1983, Childhood tuberculosis in Sweden, Tubercle 64:101–110.
von Reyn, C. F., Waddell, R. D., Eaton, T., et al., 1993, Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire and Kenya, J. Clin. Microbiol. 31:3227–3230.
Collins, F. M. 1986, Mycobacteriu avium-complex infection and the development of acquired immunodeficiency syndrome (AIDS): A casual opportunist or a causal cofactor?, Int. J. Leprosy 54:458–474.
von Reyn, C. F., Barber, T. W., Arbeit, R. D., Sox, C. H., et al., 1993, Evidence of previous infection with Mycobacterium avium-M. intracellulare complex among healthy subjects: An international study of dominant mycobacterial skin test reactions, J. Infect. Dis. 168:1553–1558.
Bates, J. H., 1996, The tuberculin skin test and preventive treatment for tuberculosis, in Tuberculosis (W. N. Rom and S. M. Garay, eds.), Little Brown, Boston, pp. 865–871.
Chin, D. P., Hopewell, P. C., Yajko, D. M., Vittinghoff, E., et al., 1994, Mycobacterium avium-complex in the respiratory or gastrointestinal tract and the risk of M. avium-complex bacteremia in patients with human immunodeficiency virus infection, J. Infect. Dis. 169:289–295.
Crawford, J. L., 1993, Applications of molecular methods in epidemiology of tuberculosis, Res. Microbial. 144:111–116.
Wolinsky, E., 1981, When is an infection disease?, Rev. Infect. Dis. 3:1025–1027.
Schaefer, W. F., Davis, C. L., and Cohn, M. L., 1970, Pathogenicity of translucent, opaque and rough variants of M. avium in chickens and mice, Am. Rev. Respir. Dis. 123:343–358.
Moulding, T., 1978, The relative drug susceptibility of opaque colony forms of M. intracellulare-avium: Does it affect therapeutic results?, Am. Rev. Respir. Dis. 117:1142–1143.
Belisle, J. T., and Brennan, P. J., 1994, Molecular basis of colony morphology in Mycobacterium avium, Res. Microbiol. 145:237–242.
Barrow, W. W., and Brennan, P. J., 1982, Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens, J. Bacteriol. 150:381–384.
Shiratsuchi, H., Toosi, Z., Mettler, M. A., and Ellner, J. J., 1993, Colonial morphotype as a determinant of cytokine expression by human monocytes infected with Mycobacerium avium, J. Immunol. 150:2945–2954.
Rastogi, N., Frehl, C., Ryter, A., et al., 1981, Multiple drug-resistance in M. avium: Is the wall architecture responsible for the exclusion of antimicrobial agents?, Antimicrob. Agents Chemother. 20:666–667.
Runyon, E. H., Karlson, A. G., Kubica, G. P., and Wayne, G. P., 1974, Mycobacterium, in Manual of Clinical Microbiology (E. H. Lennette, E. H. Spalding, and J. P. Truant, eds.), ASM, Washington, D.C., pp. 148–174.
Iseman, M. D., 1989, Mycobacterium avium complex and the normal host: The other side of the coin, N. Engl. J. Med. 321:896–898.
Falkinham, J. O., 1996, Epidemiology of infection by nontuberculosis mycobacteria. Clin. Microbiol. Rev. 9:177–215.
Good, R. C., and Snider, D. E., 1982, Isolation of nontuberculous mycobacteria in the United States, J. Infect. Dis. 146:829–833.
Good, R. C., 1985, Opportunistic pathogens in the genus Mycobacterium, Annu. Rev. Microbiol. 39:347–369.
Bates, J. H., 1996, The tuberculin skin test and preventive treatment for tuberculosis, in: Tuber-culosis (W. N. Rom and s. M. Garay, eds.), Little, Brown, Boston, pp. 865–872.
Fairchok, M. P., Rouse, J. H., and Morris, S. L., 1995, Age-dependent humoral responses of children to mycobacterial antigens. Clin. Diagn. Lab. Immunol. 2:443–447.
Portaels, F., Larsson, L., and Smeets, P., 1988, Isolation of mycobacteria from healthy persons stools. Int. J. Leprosy 56:468–471.
Williams, R. C., Hasby, G., and Koster, F. T., 1986, Well defined receptors may be entry points for infectious agents, Scand. J. Immunol. 23:529–533.
Malpother, M. E., and Sanger, J. G., 1984, In vitro interaction of Mycobacterium avium with intestinal epithelial cells, Infect. Immun. 45:67–73.
Hubbard, R. D., Flory, C. M., and Collins, F. M., 1992, T-cell immune responses in Mycobacterium avium-infected mice. Infect. Immun. 60:150–153.
Collins, F. M. and Stokes, R. W., 1987, Mycobacterium avium-complex infections in normal and immunodeficient mice, Tubercle 68:127–136.
Stokes, R. W., and Collins, F. M., 1990, Passive transfer of immunity to Mycobacterium avium in susceptible and resistant strains of mice, Clin. Exp. Immunol. 81:109–115.
Lagrange, P. H., 1978, Comparative studies of different strains of BCG vaccine in mice: T-cell dependent immune responses, Dev. Biol. Stand. 38:223–229.
Collins, F. M., 1989, Mycobacterial disease, immunosuppression and acquired immunodeficiency syndrome, Clin. Microbiol. Rev. 2:360–377.
Collins, F. M., 1991, Pulmonary tuberculosis: The immunology of a chronic infection, in: Vaccines and Immunotherapy (S. J. Cryz, ed.), Pergamon Press, New York, pp. 140–155.
Collins, F. M., Morrison, N. E., and Montalbine, V., 1978, Immune response to persistent mycobacterial infection in mice, Infect. Immun. 19:430–438.
Reddy, V. M., Parikh, K., Luna-Herrera, J., et al., 1994, Comparison of virulence of Mycobacterium avium complex (MAC) strains isolated from AIDS and non-AIDS patients, Microbiol. Pathogen. 16:121–130.
Goto, Y., Nakamura, R. M., Takahashi, H., and Tokunaga, T., 1984, Genetic control of resistance to Mycobacterium intracellulare infections in mice, Infect. Immun. 46:135–140.
Barnes, P. F., Modlin, R. L., and Ellner, J. J., 1994, T-cell responses and cytokines, in: Tuberculosis: Pathogenesis, Protection and Control (B. R. Bloom, ed.), ASM, Washington, D.C., pp. 417–435.
Ellner, J. J., Goldberger, M. J., and Parenti, D. M., 1991, Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution, J. Infect. Dis. 163:1326–1335.
Abbott, M. R., and Smith, D. D., 1981, Mycobacterial infections in immunosuppressed patients, Med. J. Austr. 1:351–353.
Feld, R., Bodey, G. P., and Groschel, D., 1976, Mycobacteriosis in patients with malignant disease, Arch. Intern. Med. 136:67–70.
Watson, S. R., Morrison, N. E., and Collins, F. M., 1979, Delayed hypersensitivity responses in mice and guinea pigs to Mycobacterium leprae, M. vaccae and M. nonchromogenicum cytoplasmic proteins, Infect. Immun. 25:229–236.
Gordin, F., and Masur, H., 1994, Prophylaxis of M. avium complex bacteremia in patients with AIDS, Clin. Infect. Dis. 18:S223–226.
Bermudez, L. E., 1994, Immunobiology of Mycobacterium avium infection, Eur. J. Clin. Microbiol. Infect. Dis. 13:1000–1006.
Orme, I. M., 1993, Immunity to mycobacteria, Curr. Opinion Immunol. 5:497–502.
McCune, R. M., Feldman, F. M., Lambert, H. P., and McDermott, W., 1966, Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues, J. Exp. Med. 123:455–468
de Wit, D., Wooton, M., Dhillon, J., and Mitchison, D. A., 1995, The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis, Tubercle Lung Dis. 76:555–562.
Grange, J. M., 1992, The mystery of the mycobacterial ‘persistor’, Tubercle Lung Dis. 73:249–251.
Khansari, D. N., Murgo, A. J., and Faith, R. E., 1990, Effects of stress on the immune system, Immunol. Today 10:170–175.
Stead, W. W., 1989, Special problems in tuberculosis. Tuberculosis in the elderly and in residents of nursing homes, correctional facilities, long-term hospitals, mental hospitals, shelters for the homeless and jails, Clin. Chest Med. 10:397–405.
Orme, I. M., 1989, Aging and immunity to tuberculosis: Prolonged survival of old mice infected with Mycobacterium tuberculosis by adoptive immunization with memory-immune T lymphocytes, Cell. Immunol. 118:229–233.
North, R. J., 1993, Minimal effect of advancing age on susceptibility of mice to infection by Mycobacterium tuberculosis, J. Infect. Dis. 168:1059–1062.
Fauci, A. S., 1984, Acquired immunodeficiency syndrome: Epidemiologic, immunologic and therapeutic considerations, Ann. Intern. Med. 100:92–106.
Collins, F. M., 1990, Bacterial cofactors in AIDS, in: Cofactors in HIV-1 infection and AIDS (R. R. Watson, ed.), CRC Press, Boca Raton, FL, pp. 61–78.
Morrissey, A. B., Aisa T. O., Falkinham, J. O., et al., 1992, Absence of M. avium complex disease in patients with AIDS in Uganda, J. AIDS 5:477–478.
Horsburgh, C. R., Hanson, D. L., Jones, J. L., and Thompson, S. E., 1996, Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis, J. Infect. Dis. 174:1212–1217.
Gilks, C. F., Brindle, R. J., Mwachari, C., et al., 1995, Disseminated M. avium infection among HIV-infected patients in Kenya, J. AIDS 8:195–198.
Pitchenik, A. E., Cole, C., Russell, B. W., et al., 1984, Tuberculosis, atypical mycobacteriosis and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in South Florida, Ann. Intern. Med. 101:641–645.
Horsburg, C. R., Chin, D. P., Yajko, D. M., et al., 1994, Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection, J. Infect. Dis. 170:362–367
von Reyn, C. F., Jacobs, N. J., Arbeit, R. D., et al., 1995, Polyclonal Mycobacterium avium infection in patients with AIDS: Variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient, J. Clin. Microbiol 33:1008–1010.
von Reyn, C. F., Green, P. A., McCormick, D., et al., 1994, Dual skin testing with M. avium sensitin and purified protein derivative: An open study of patients with M. avium-complex infection or tuberculosis, Clin. Infect. Dis. 19:15–20.
Lucas, S. B., Hounnou, A., Peacock, C. S., et al., 1993, The mortality and pathology of HIV disease in a West African city, AIDS 7: 1569–1579.
Welch, K., Finkbeiner, W., Alpers, C. E., et al., 1984, Autopsy findings in the acquired immune deficiency syndrome, JAMA 252:1152–1159.
Crawford, J. L., 1994, Development of rapid techniques for identification of Mycobacterium avium infections, Res. Microbiol. 145:171–178.
Woods, G. L., 1994, Disease due to Mycobacterium avium complex in patients infected with human immunodeficiency virus: Diagnosis and susceptibility testing, Clin. Infect. Dis. 18:S227–232.
Jost, K. C., Dunbar, D. F., Barth, S. S., et al., 1995, Identification of M. tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models, J. Clin. Microbiol. 33: 1270–1277.
Jacobs, W. R., Barletta, R. G., Udani, R., et al., 1993, Rapid assessment of drug susceptibilities of M. tuberculosis by means of luciferase reporter genes, Science 260:819–822.
Roth, R. J., Owen, R. L., and Keren, D. F., 1983, AIDS with M. avium-intracellularelesions resembling those of Whipple’s disease, N. Engl. J. Med. 309: 1324–1325.
Hellyer, T. J., Brown, I. N., Taylor, M. B., et al., 1993, Gastrointestinal involvement in M. avium-intracellulare infection in patients with HIV, J. Infect. 26:55–66.
Montecalvo, M. A., Forester, G., Tsang, A. Y., et al., 1994, Colonization of potable water with Mycobacterium avium complex in homes of HIV-infected patients, Lancet 343:1639.
Morris, A., Reller, L. B., Salfinger, M., et al., 1993, Mycobacteria in stool samples: The non-value of smears for predicting culture results, J. Clin. Microbiol. 31:1385–1387.
Li, Z., Bai, G. H., von Reyn, C. F., et al., 1996, Rapid detection of M. avium in stool samples from AIDS patients by immunomagnetic PCR, J. Clin. Microbiol. 34:1903–1907.
Nash, G., and Fliegel, S., 1984, Pathological features of the lung in acquired immune deficiency syndrome (AIDS): An autopsy study of seventeen homosexual males, Am. J. Clin. Pathol. 81:6–12.
Morrison, N. E., and Collins, F. M., 1975, Immunogenicity of an aerogenic BCG vaccine in T-cell depleted and normal mice, Infect. Immun. 11:1110–1121.
North, R. J., and Izzo, A. A., 1993, Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection, Am. J. Pathol. 142:1959–1966.
Centers for Disease Control, 1992, Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system-New York, Morb. Mort. Wk. Rep. 41:507–509.
Goletti, D., Weissman, D., Jackson, R. W., et al., 1996, Effect of Mycobacterium tuberculosis in HIV replication: Role of immune activation, J. Immunol. 157:1271–1278.
Horsburg, C. R., and Selik, R. M., 1989, The epidemiology of disseminated tuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS), Am. Rev. Respir. Dis. 139:4–7.
Olliaro, P., and Dautzenberg, B., 1994, Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: A prospective trial with rifabutin combined with isoniazid, clofazimine and ethambutol, J. Chemother. 6:189–196.
Gordin, F., and Masur, H., 1994, Prophylaxis of M.avium-complex bacteremia in patients with AIDS, Clin. Infect. Dis. 18:S223–226.
Young, L. S., 1996, Mycobacterial infections in immunocompromised patients. Curr. Opinion Infect. Dis. 9:240–245.
Chin, D. P., Reingold, A. L., Stone, E. N., et al., 1994, The impact of Mycobacteriumavium complex bacteremia and its treatment or survival of AIDS patients—a prospective study. J. Infect. Dis. 170:578–584.
Stanford, J. L., and Grange, J. M., 1994, The promise of immunotherapy for tuberculosis, Respir. Med. 88:3–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Collins, F.M. (2002). Mycobacterium avium-Complex Infections and Immunodeficiency. In: Opportunistic Intracellular Bacteria and Immunity. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46809-3_7
Download citation
DOI: https://doi.org/10.1007/0-306-46809-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45894-1
Online ISBN: 978-0-306-46809-4
eBook Packages: Springer Book Archive